Omixon Announce Dimitri Monos as Chair of its Scientific Advisory Board

25/02/2016

Omixon announced today that Dr. Dimitri Monos, Director of the Immunogenetics Laboratory of The Children’s Hospital of Philadelphia (CHOP) and Professor of Pathology and Laboratory Medicine at Perelman School of Medicine of the University of Pennsylvania, will join their team as Chair of the company’s Scientific Advisory Board. Professor...

Working with True Lies – Statistics in Biology

23/02/2016

Meet Fred. This story starts with a hypothetical PhD student. Let’s call him Fred. Fred is doing a PhD in food science and has a vegetarian flat-mate (let’s call her Karen). After living with Karen for a few months, Fred noticed that Karen and her vegetarian friends eat a...

Join Our Upcoming Webinar – Changes on Allele Frequencies Net Database to Support NGS in Histocompatibility & Immunogenetics

01/02/2016

Join us at our Omixon Webinar to discover the changes happening to the allele frequencies database and the impact of NGS on histocompatibility and immunogenetics. The disruptive power of Next Generation Sequencing is reshaping the nature of modern Immunogenetics with the ability to fully characterize the necessary HLA genes for every patient. Omixon Holotype HLA...

Join Our Upcoming Webinar – Changes on Allele Frequencies Net Database to Support NGS in Histocompatibility & Immunogenetics

01/02/2016

Omixon Announce French Tender Victory

27/01/2016

Omixon today announce that their flagship Holotype HLA assay and software solution for HLA typing by Next Generation Sequencing (NGS) has been selected as the HLA typing solution of choice by the Etablissement Français du Sang (the French National Blood Service, EFS). Omixon won a two-year competitive tender worth...